CVMP Summary Opinion on Fenvalerate

Document Sample
CVMP Summary Opinion on Fenvalerate Powered By Docstoc
					                                                The European Agency for the Evaluation of Medicinal Products




                                                                                                           London, 19 March 2004
                                                                                                            EMEA/CVMP/347/04



                              SUMMARY OPINION∗
            OF THE COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
               ON THE ESTABLISHMENT OF MAXIMUM RESIDUE LIMITS


                                                        FENVALERATE


 On 17 March 2004 the Committee for Veterinary Medicinal Products adopted an Opinion∗∗
 recommending the extension of Provisional maximum residue limits in accordance with Council
 Regulation (EEC) No 2377/90, as amended, for fenvalerate for bovine species, as follows:


     Pharmacologically                 Marker              Animal            MRLs             Target          Other provisions
     active substance(s)               residue             species                            tissue
     Fenvalerate                   Fenvalerate           Bovine            25 µg/kg        Muscle           Provisional MRLs
                                   (sum of RR,                            250 µg/kg        Fat              expire on
                                   SS, RS and                              25 µg/kg        Liver            1.7.2006
                                   SR isomers)                             25 µg/kg        Kidney
                                                                           40 µg/kg        Milk




 ∗
   Summaries of opinion are published without prejudice to the Commission Decision, which will normally be issued within
 90 days from adoption of the Opinion.
 ∗∗
    Applicants may appeal any CVMP opinion, provided they notify the EMEA in writing of their intention to appeal within
 15 days of receipt of the opinion.
                                                7 Westferry Circus, Canary Wharf, London, E14 4HB, UK
                                                    Tel. (44-20) 74 18 84 00 Fax (44-20) 74 18 84 47
                                                   E-mail: mail@emea.eu.int http://www.emea.eu.int
EMEA 2004 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged